CAC Software vs TeraRecon Cardiovascular.Calcification.CT

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Both Imbio's CAC Software and TeraRecon Cardiovascular.Calcification.CT are FDA-cleared, AI-powered tools designed for automated coronary artery calcification analysis from CT scans, providing metrics like the Agatston score. While Imbio's tool focuses specifically on CAC quantification and risk assessment, TeraRecon's offering appears to be a module within a broader CT Cardiac package, providing additional features like vessel and cardiac structure segmentation and analysis. Therefore, they are direct competitors for CAC scoring, with TeraRecon offering a potentially more comprehensive cardiac imaging solution.

Choose CAC Software if…

Choose Imbio's CAC Software if your primary need is a dedicated, efficient, and standalone solution for quantifying coronary artery calcification from non-contrast chest CTs. This tool is ideal for clinics prioritizing detailed 3D visualizations, specific metrics like arterial age, and seamless integration into their existing DICOM viewing workflow for robust cardiovascular risk assessment.

View CAC Software →

Choose TeraRecon Cardiovascular.Calcification.CT if…

Choose TeraRecon Cardiovascular.Calcification.CT if you require a more comprehensive cardiac imaging analysis platform that extends beyond basic calcium scoring. This solution is best suited for institutions seeking advanced capabilities such as detailed vessel segmentation, plaque characterization, cardiac functional analysis, or pre-operative planning for electrophysiology procedures, all within a unified CT Cardiac package.

View TeraRecon Cardiovascular.Calcification.CT →

For physicians evaluating AI tools for coronary artery calcification (CAC) assessment, Imbio’s CAC Software and TeraRecon Cardiovascular.Calcification.CT offer distinct advantages. Imbio’s solution excels at providing a comprehensive, automated post-processing analysis of non-contrast chest CTs, directly outputting key metrics like the Agatston score, arterial age, calcified lesion mass, and volume. It also offers 3D visualizations and annotated images, integrating seamlessly into existing DICOM viewing workflows. This makes it particularly well-suited for radiologists and cardiologists primarily focused on detailed, quantitative CAC assessment and risk stratification from standard chest CTs.

TeraRecon Cardiovascular.Calcification.CT, while also providing automatic detection and measurement of coronary calcifications and supporting Agatston, volume, and mean mass scores, is part of a broader CT Cardiac package. A key practical difference is its extended capabilities, including zero-click centerline creation, vessel segmentation and analysis (plaque, stenosis, curvature, tortuosity), and cardiac structure segmentation with functional analysis. This makes TeraRecon a more robust choice for cardiologists and cardiothoracic surgeons who require a comprehensive suite of cardiac CT analysis tools beyond just CAC scoring, encompassing pre-operative evaluation and EP planning. Physicians whose primary need is a dedicated, in-depth CAC analysis from non-contrast CTs would likely find Imbio’s focused approach more direct, while those needing a wider array of cardiac CT analysis features should consider TeraRecon’s integrated platform.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software TeraRecon Cardiovascular.Calcification.CT
Pricing Contact for pricing Subscription-based
Deployment Cloud, On-premise, Partner platforms Containerized application (SaMD), also available as SaaS within Eureka Clinical AI platform.
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

TeraRecon Cardiovascular.Calcification.CT

While both tools integrate into existing DICOM viewing workflows and offer automation, TeraRecon's solution, particularly through its Eureka Clinical AI platform, provides explicit physician engagement tools for validating AI findings and a web-based interactive results explorer, suggesting a more refined and interactive user experience.

Clinical Value

TeraRecon Cardiovascular.Calcification.CT

While both provide robust coronary artery calcification analysis, TeraRecon's solution is part of a comprehensive CT Cardiac package offering a wider array of features such as vessel segmentation, cardiac structure and functional analysis, and EP planning, providing greater overall clinical utility.

Pricing & Value

TeraRecon Cardiovascular.Calcification.CT

TeraRecon offers a more transparent subscription-based pricing model with a single annual fee, which provides clear operational budget flexibility and eliminates annual service renewals. Imbio's pricing requires direct contact, offering less immediate clarity on cost structure.

Enterprise Readiness

TeraRecon Cardiovascular.Calcification.CT

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, BAA, and flexible deployment options. However, TeraRecon's ISO 27001:2022 certification and its Eureka Clinical AI platform's vendor-agnostic approach for integrating various AI algorithms and supporting desktop and mobile applications give it an edge in comprehensive enterprise integration and security.

Innovation

TeraRecon Cardiovascular.Calcification.CT

While both leverage deep learning for automated analysis, TeraRecon demonstrates greater innovation through its Eureka Clinical AI platform, which serves as a vendor-agnostic interoperability framework for integrating diverse AI algorithms, including third-party and custom solutions, and offers advanced features like 'zero-click centerline creation.'

Support & Docs

TeraRecon Cardiovascular.Calcification.CT

Both companies provide accessible technical support and documentation. However, TeraRecon offers a more comprehensive support ecosystem, including online customer training webinars, on-site application training, and a 'Premier Success' program, which indicates a stronger commitment to ongoing user education and optimization.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software TeraRecon Cardiovascular.Calcification.CT
Name CAC Software TeraRecon Cardiovascular.Calcification.CT
Company Imbio Terarecon
Primary Analysis Focus Automated image post-processing for coronary artery calcification, quantification of calcification Automatically detect and measure calcifications in the coronary arteries, providing a mask for calcium scoring systems
Supported Calcification Scores/Measurements Agatston score, arterial age, calcified lesion mass and volume Agatston score, volume, mean mass (mg) measurements
Additional Cardiac Analysis Capabilities Provides 3D visualizations and annotated images; supports risk assessment for coronary artery disease Automatic 3D segmentation of calcified plaques; part of CT Cardiac package with zero-click centerline creation; vessel segmentation and analysis (plaque, stenosis, curvature, tortuosity); cardiac structure segmentation and functional analysis; atrium & pulmonary vein analysis for EP planning; pre-operative evaluation of coronary arteries

Videos

Demos, reviews, and walkthroughs featuring CAC Software and TeraRecon Cardiovascular.Calcification.CT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's CAC Software outputs the Agatston score, arterial age, calcified lesion mass, and volume. TeraRecon Cardiovascular.Calcification.CT provides the Agatston score, volume, and mean mass (mg), along with a mask for calcium scoring systems.
Imbio's CAC Software is designed to integrate into existing DICOM viewing workflows. TeraRecon Cardiovascular.Calcification.CT is available as a containerized application (SaMD) or as SaaS within their Eureka Clinical AI platform.
Imbio's CAC Software primarily focuses on automated image post-processing for CAC quantification and risk assessment. TeraRecon Cardiovascular.Calcification.CT is part of a broader CT Cardiac package, offering additional features like vessel segmentation and analysis, cardiac structure segmentation, and functional analysis for applications such as EP planning.
For Imbio's CAC Software, pricing details require direct contact with the company. TeraRecon Cardiovascular.Calcification.CT operates on a subscription-based model with a single annual fee, which aims to eliminate annual service renewals and provide operational budget flexibility.
Imbio's CAC Software provides 3D visualizations and annotated images to aid in analysis. TeraRecon Cardiovascular.Calcification.CT offers automatic 3D segmentation of calcified plaques and outputs a mask specifically for calcium scoring systems.
AI Tool Finder
AI-powered search. Results may not be comprehensive.